This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Chesapeake, Health Net, Molson Coors, Ralph Lauren, Visteon Set to Report

Stock quotes in this article: CHK, HNT, RL, TAP, VC

Health Net ($42.64) spiked to a 52-week high at $45.61 on July 24, and declined to its 50-day SMA at $41.53, trading as low as $41 on Friday. The stock is well above its 200-day SMA at $34.53.

Analysts expect the company to report earnings of 56 cents per share. Health Net has a 12-month trailing P/E ratio of 21 and doesn't pay a dividend.

The weekly chart shifts to negative given a close this week below its five-week MMA at $41.85. Quarterly and semiannual value levels are $38.49 and $37.78, respectively, with a monthly pivot at $42.16 and weekly risky level at $44.12.

Ralph Lauren ($156.30) has been below its 200-day SMA at $161.57 since July 10, trading as low as $153.87 on Friday.

Analysts expect the company to report earnings of $1.75 per share. It has a 12-month trailing P/E ratio of 18.7 and dividend yield of 1.2%.

The weekly chart is negative with its five-week MMA at $157.06 and the 200-week SMA at $151.64. A monthly value level is $142.45 with an annual pivot at $154.30 and weekly and annual risky levels at $160.85 and $168.38, respectively.

Molson Coors ($67.90) set an all-time intraday high at $75.55 on June 20, and traded as low as $67 on Friday, which was well below its 50-day SMA at $70.77 and well above its 200-day SMA at $60.02.

Analysts expect the company to report earnings of $1.44 per share. It has 12-month trailing P/E ratio of 16.3 and dividend yield of 2.2%.

The weekly chart is negative with its five-week MMA at $69.75. Semiannual and annual value levels are $62.38 and $60.54, respectively, with a quarterly pivot is $67.88 and monthly and weekly risky levels at $71.00 and $76.99, respectively.

Visteon ($98.81) set an all-time intraday high at $100.79 on July 7, and traded as low as $94.23 on Thursday, compared with its 50-day SMA at $95.65. The stock is well above its 200-day SMA at $85.92.

Analysts expect the company to report earnings of 75 cents per share. It has a 12-month trailing P/E ratio of 22 and doesn't pay a dividend.

The weekly chart is neutral with its five-week MMA at $96.45 and its 200-week SMA down at $62.97. Semiannual value levels are $93.29 and $72.29, with a monthly pivot at $98.60 and weekly and quarterly risky levels at $99.29 and $107.56, respectively.

Abercrombie Is Seen on the Recovery Road

2 of 4

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,888.71 -154.19 -0.90%
S&P 500 1,958.92 -13.37 -0.68%
NASDAQ 4,451.8310 -41.5590 -0.92%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs